Rare Disease
Leber Hereditary Optic Neuropathy: A Giving Smarter Guide
Leber Hereditary Optic Neuropathy: A Giving Smarter Guide
It is believed that there are as many as 8,000 rare diseases collectively affecting one in ten people around the world. These diseases are extremely difficult to diagnose, in part because there is little recognition of the symptoms or consensus on diagnostic criteria. For example, some people with rare diseases can go as many as ten years (and some have gone even longer) before getting to a proper diagnosis, only to find that treatments are hard to come by, ineffective, and/or cause debilitating side effects. They also may experience the loneliness and hopelessness that results from a condition that is not widely discussed, and are thus less likely to have a community that provides support or empathy.
From misophonia to sarcoidosis, the Milken Institute has worked with donors with firsthand experience of rare and difficult to diagnose conditions, bringing experts from multiple sectors and fields together with patients [people with lived experiences] to understand the landscape and work toward better diagnostics and treatments.
Current Research Programs
CAMK2-Related Neurodevelopmental Disorders
Leber Hereditary Optic Neuropathy
Misophonia
Rare Disease
Highlights
-
Uterine Leiomyosarcoma: A Giving Smarter Guide
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...Read Report -
Artificial Intelligence, Precision Medicine, and Neurodegenerative Disease: A Giving Smarter Guide
Neurodegenerative diseases (ND), including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, and others, affect over 50 million people worldwide. The World Health Organization estimates that by the year 2040, NDs will be...Read Report -
Leber Hereditary Optic Neuropathy: A Giving Smarter Guide
Leber Hereditary Optic Neuropathy (LHON) is a rare disease that causes sudden, irreversible loss of vision, often striking during adolescence or early adulthood. Patients with LHON quickly lose their ability to recognize faces, drive, and...Read Report -
Consensus Definition of Misophonia A Delphi Study
Misophonia was named and described in the early 2000’s (Jastreboff and Jastreboff, 2001, 2002) and has since gained scientific recognition and clinical identification across a wide variety of disciplines (e.g., audiology, neuroscience...Read Report -
Sarcoidosis: A Giving Smarter Guide
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have released a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis. Applications are open through January 20...Read Report -
Type 1 Diabetes Autoantibody Screening: A Roadmap for Pediatric Policy Implementation
Type 1 diabetes, or T1D, once commonly known as juvenile diabetes, is an autoimmune disease in which the immune system attacks the insulin-producing cells of the pancreas. The disease affects people of all ages and causes numerous negative...Read Report -
Misophonia - A Giving Smarter Guide
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...Read ReportJR
-
Targeting Tau — Our Hope to Solving the Dementia Crisis
In our systems-based review of the biomedical landscape supporting research of a cellular protein called tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and...Read Report -
Neurofibromatosis Preclinical Initiatives (NFPI)
The NF Preclinical Initiative (NFPI) represents one of the Children’s Tumor Foundation’s groundbreaking models of scientific collaboration. The NFPI is aimed at accelerating proof of concept testing of potential effective repurposed drugs...Read Report
Our Team
Cara Altimus, PhD
Caitlyn Barrett, PhD
Elizabeth Burke, PhD
Ishtiaq Mawla, PhD